1NKEMIA Logo

1NKEMIA

A tech group providing R&D, services, training, and investment for life sciences industries.

IKM | BME Growth

Overview

Corporate Details

ISIN(s):
ES0156303002
LEI:
959800QRRHKJ6C8MW495
Country:
Spain
Address:
C/Alvarez de Castro 63, 08100 Mollet del Vallès
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

1NKEMIA IUCT Group S.A., founded in 1997, is a technology group focused on the generation and commercial exploitation of knowledge for the life sciences sector. The company provides open R&D, technological services, and training to the chemical, pharmaceutical, biotechnological, cosmetic, and nutraceutical industries. Functioning as a business incubator and investment vehicle, 1NKEMIA actively acquires and holds stakes in high-tech SMEs. The group also manages the 'Fondo Capital Conocimiento' (Knowledge Capital Fund) to foster entrepreneurship and support the development of innovative technologies and startups.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all 1NKEMIA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 1NKEMIA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 1NKEMIA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-26 Björn Zethraeus Other Other 6,646 66,460,000.00 SEK
2025-05-24 Anders Nilsson Other Other 10,000 326,900.00 SEK
2025-05-23 marius balger Other Sell 45,000 534,150.00 SEK
2025-05-23 Todd Heringer Other Other 150,000 N/A
2025-05-22 Klaudija Cavala Other Other 100,000 22,000.00 SEK
2025-05-20 Gionata La Torre Other Buy 31,182 951,051.00 SEK
2025-05-20 Karl-Emil Engström Other Sell 5,000 279,350.00 SEK
2025-05-20 Christina Thérèse Hersch Fagerberg Other Sell 1,000 55,870.00 SEK
2025-05-20 Gionata La Torre Other Buy 31,182 N/A
2025-05-19 Erik Gjötterberg Other Other 15,000 311,550.00 SEK

Peer Companies

Inotiv, Inc. Logo
CRO providing nonclinical drug discovery, research models, and analytical services for life sciences.
United States of America
NOTV
IntegraGen Logo
Genomic analysis & molecular diagnostics for cancer and rare diseases for researchers and labs.
France
ALINT
Intellia Therapeutics, Inc. Logo
Developing curative CRISPR/Cas9 genome editing therapies for severe genetic disorders.
United States of America
NTLA
InterDigital, Inc. Logo
Develops and licenses essential wireless, video, and AI technologies for mobile devices and networks.
United States of America
IDCC
IntoCell, Inc. Logo
Develops and licenses proprietary ADC platform technologies for cancer & immune therapies.
South Korea
287840
Inventage Lab Inc. Logo
Develops drug delivery systems using microfluidics for chronic diseases and gene therapies.
South Korea
389470
Investeko Spolka Akcyjna Logo
Offers environmental consulting, R&D, and design for commercial eco-innovations.
Poland
IVE
IQVIA HOLDINGS INC. Logo
Global provider of analytics, tech, and clinical research for life sciences and healthcare.
United States of America
IQV
Isofol Medical Logo
Developing a drug to enhance chemotherapy efficacy for solid tumors like colorectal cancer.
Sweden
ISOFOL

Talk to a Data Expert

Have a question? We'll get back to you promptly.